Cancer

By Hongjiang Li | Mar 7, 2018 | 7:15 PM GMT

INDICATION: Breast cancer

Cell culture studies suggest inhibiting NEK9 or MAP2K4 could help treat PI3K inhibitor-resistant triple-negative breast cancer (TNBC).